These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Friedland RP; Budinger TF; Koss E; Ober BA Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424 [TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography in Alzheimer's disease. Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046 [TBL] [Abstract][Full Text] [Related]
30. Landau-Kleffner syndrome: metabolic abnormalities in temporal lobe are a common feature. da Silva EA; Chugani DC; Muzik O; Chugani HT J Child Neurol; 1997 Nov; 12(8):489-95. PubMed ID: 9430313 [TBL] [Abstract][Full Text] [Related]
31. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. Friedland RP; Prusiner SB; Jagust WJ; Budinger TF; Davis RL J Comput Assist Tomogr; 1984 Oct; 8(5):978-81. PubMed ID: 6381559 [TBL] [Abstract][Full Text] [Related]
32. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Gur RE; Mozley PD; Resnick SM; Mozley LH; Shtasel DL; Gallacher F; Arnold SE; Karp JS; Alavi A; Reivich M Arch Gen Psychiatry; 1995 Aug; 52(8):657-67. PubMed ID: 7632119 [TBL] [Abstract][Full Text] [Related]
33. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603 [TBL] [Abstract][Full Text] [Related]
34. PET studies of cerebral glucose metabolism in conscious rhesus macaques. Eberling JL; Roberts JA; De Manincor DJ; Brennan KM; Hanrahan SM; Vanbrocklin HF; Roos MS; Jagust WJ Neurobiol Aging; 1995; 16(5):825-32. PubMed ID: 8532117 [TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. DeLisi LE; Holcomb HH; Cohen RM; Pickar D; Carpenter W; Morihisa JM; King AC; Kessler R; Buchsbaum MS J Cereb Blood Flow Metab; 1985 Jun; 5(2):201-6. PubMed ID: 2859295 [TBL] [Abstract][Full Text] [Related]
36. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Buchsbaum MS; DeLisi LE; Holcomb HH; Cappelletti J; King AC; Johnson J; Hazlett E; Dowling-Zimmerman S; Post RM; Morihisa J Arch Gen Psychiatry; 1984 Dec; 41(12):1159-66. PubMed ID: 6334502 [TBL] [Abstract][Full Text] [Related]
37. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ho SS; Berkovic SF; Berlangieri SU; Newton MR; Egan GF; Tochon-Danguy HJ; McKay WJ Ann Neurol; 1995 Jun; 37(6):738-45. PubMed ID: 7778847 [TBL] [Abstract][Full Text] [Related]
39. Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus. Handforth A; Cheng JT; Mandelkern MA; Treiman DM Epilepsia; 1994; 35(4):876-81. PubMed ID: 8082637 [TBL] [Abstract][Full Text] [Related]
40. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Theodore WH; Sato S; Kufta CV; Gaillard WD; Kelley K Epilepsia; 1997 Jan; 38(1):81-6. PubMed ID: 9024188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]